FDA Adverse Event Injury Summary report: N

SEE H-10

MDR report key: 2152720 · Received July 7, 2011

Report

Report Number
2023826-2011-00605
Event Type
Injury
Date Received
July 7, 2011
Date of Event
May 26, 2011
Report Date
June 9, 2011
Manufacturer
STAAR SURGICAL COMPANY
Product Code
HQL
PMA / PMN Number
P880091
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

SILICONE ULTRAVIOLET-ABSORBING POSTERIOR CHAMBER SINGLE PIECE FOLDABLE INTRAOCULAR LENS (ELASTIC). (B)(4). EVALUATION: RESULTS: VISUAL INSPECTION OF THE RETURNED PRODUCT SHOWED EVIDENCE OF A CLEAR SURGICAL RESIDUE, HOWEVER, THERE WAS NO VISIBLE DAMAGE TO THE LENS. BOTH SIDES OF THE OPTIC/HAPTICS WERE CHECKED FOR ROUGH/SHARP EDGES AND EDGES WERE FOUND TO BE ACCEPTABLE. (B)(4).

Additional Manufacturer Narrative · 1

(B)(4). MEDICAL REVIEW - A CAPSULE TEAR IS LIKELY SECONDARY TO SURGICAL MANIPULATION BY THE SURGEON RATHER THAN THE LENS ITSELF, HOWEVER, IT REMAINS UNCLEAR WHETHER THE PRODUCT CAUSED OR CONTRIBUTED TO THIS EVENT. (B)(4)

Additional Manufacturer Narrative · 1

EVALUATION: METHOD - DEVICE HISTORY REVIEW. RESULTS: AFTER REVIEWING THE COMPLAINT FILE, DEVICE HISTORY RECORD AND PERFORMING A ROOT CAUSE ANALYSIS, THERE IS NO DIRECT EVIDENCE THAT LEADS TO THE ROOT CAUSE OF THIS COMPLAINT. THE ROOT CAUSE IS NOT LIKELY RELATED TO THE MANUFACTURING PROCESS OF THE LENS. A POSTERIOR CAPSULE TEAR IS MORE COMMONLY SECONDARY TO SURGICAL MANIPULATIONS PERFORMED BY THE SURGEON DURING INTRAOCULAR SURGERY. (B)(4).

Description of Event or Problem · 1

THE REPORTER STATED THE (B)(4) SILICONE SINGLE PIECE LENS WAS INSERTED AND REMOVED DUE TO A CAPSULE TEAR. REPLACED WITH ANOTHER STAAR LENS. ADDITIONAL INFORMATION HAS BEEN REQUESTED BUT NOT YET RECEIVED. IF ADDITIONAL INFORMATION IS OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SEE H-10 INTRAOCULAR LENS HQL STAAR SURGICAL COMPANY AA4203TL N/A

Patients

Seq Age Sex Outcome Treatment
1 69 YR